Form 4: West Pharmaceutical Services CEO Eric Green Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Eric Green, President, CEO, and Board Chair of West Pharmaceutical Services, reports the acquisition and disposal of common stock and stock options.

Summary

  • On February 18, 2025, Eric Green, the President, CEO, and Board Chair of West Pharmaceutical Services, engaged in transactions involving the company's stock.
  • Green acquired 2,460.991 shares of common stock at a price of $211 per share.
  • He also disposed of 700.296 shares of common stock at $211 per share to cover tax obligations.
  • Following these transactions, Green directly owns 169,668.8195 shares of West Pharmaceutical Services common stock.
  • Green also acquired 12,149 stock options with an exercise price of $211, exercisable beginning February 18, 2026, and expiring on February 18, 2035.
  • He also acquired 5,256 restricted stock units that vest in four equal installments beginning on February 18, 2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and ownership.

Key Dates

DateDescription
May 13, 2024Date of Power of Attorney execution.
February 18, 2025Date of stock transactions and grant of stock options and restricted stock units.
February 18, 2026First vesting date for stock options and restricted stock units.
February 18, 2035Expiration date for stock options.
February 20, 2025Date of signature for the Form 4 filing.

Keywords

Form 4, Section 16(a), Beneficial Ownership, Stock Options, Restricted Stock Units, Eric Green, West Pharmaceutical Services, WST

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.